bpc-157 human clinical trials evidence safety regulatory status fda warning Approval Status: Is It Approved for Use? BPC-157 Legal Status: FDA Regulations

The first phase is the direct stimulation of sensory nerve endings by formalin, which causes acute pain as an inflammatory response, and the second phase causes persistent pain by central sensitization

Botond, et al

Their core value lies in synergizing with conventional treatments to enhance efficacy and reduce adverse effects, addressing unmet needs in ADs such as long-term remission maintenance and slowing early disease progression, without replacing core first-line therapies

How Might PDA Work

Cortisone Suppresses inflammation Fast symptom relief No tissue repair Can weaken tendons with repeat use Insurance-covered BPC-157 Promotes repair + angiogenesis Slower onset (1-3 weeks) Builds new tissue Favorable safety profile Cash-pay only ($250/mo) PRP Concentrated growth factors Moderate onset (2-6 weeks) Stimulates tissue repair Uses your own blood Sometimes insurance-covered COST AT MOONSHOT At Moonshot Medical in Park Ridge, IL, we focus on peptide-based recovery protocols: $250/mo BPC-157 at Moonshot Medical $394/mo Wolverine Blend (BPC-157 + TB-500) 503A Sourced Licensed compounding pharmacy, pharmaceutical grade We don't currently offer PRP